When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Amicus Therapeutics (NASDAQ:FOLD) announces positive 24-month results from a Phase 1/2 clinical trial, ATB200-02, evaluating AT-GAA in patients with an inherited lysosomal storage disorder called Pompe disease. The data are being presented at the WORLDSymposium in Orlando, FL.
More news on: Amicus Therapeutics, Inc., Healthcare stocks news, Stocks on the move,